Search

everythinglearnresearchcommunity

for

Search:↓

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Hidradenitis suppurativa improves with antiandrogen therapy.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Mutations in certain receptors can cause diseases and offer new treatment options.

Estrogen and androgen signals control synaptic changes in rat brains.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.